Literature DB >> 952975

Control of oxidative phosphorylation by the extra-mitochondrial ATP/ADP ratio.

U Küster, R Bohnensack, W Kunz.   

Abstract

The control of mitochondrial ATP synthesis by the extramitochondrial adenine nucleotide pattern was investigated with rat liver mitochondria. It is demonstrated that any stationary state between the two limit states of maximum activity (state 3) and of resting activity (state 4) can be obtained by a hexokinase-glucose trap as an ADP-regenerating system. These intermediate states are characterized by stationary respiratory rates, stationary redox levels of the cytochromes b and c and stationary levels of extramitochondrial ATP and ADP between the rates and levels of the limit states. At a constant concentration of inorganic phosphate the activity of mitochondria between the limit states is controlled by the extramitochondrial ATP/ADP ratio independent of the total concentration of adenine nucleotides present. The control range was found to be between ratios of about 5 and 100 at 10 mM phosphate. At lower ratios the mitochondria are in their maximum phosphorylating state. With succinate+rotenone and glutamate+malate the same control range was observed, indicating that it is independent of the nature of substrate oxidized. The results suggest that in the control range the mitochondrial activity is limited by the competition of ADP and ATP for the adenine nucleotide translocator.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952975     DOI: 10.1016/0005-2728(76)90073-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Regulation of respiration and ATP synthesis in higher organisms: hypothesis.

Authors:  B Kadenbach
Journal:  J Bioenerg Biomembr       Date:  1986-02       Impact factor: 2.945

2.  Steady-state kinetics of the overall oxidative phosphorylation reaction in heart mitochondria. Determination of the coupling relationships between the respiratory reactions and miscellaneous observations concerning rate-limiting steps.

Authors:  C D Stoner
Journal:  J Bioenerg Biomembr       Date:  1984-04       Impact factor: 2.945

Review 3.  Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?

Authors:  Alexis Diaz-Vegas; Pablo Sanchez-Aguilera; James R Krycer; Pablo E Morales; Matías Monsalves-Alvarez; Mariana Cifuentes; Beverly A Rothermel; Sergio Lavandero
Journal:  Endocr Rev       Date:  2020-06-01       Impact factor: 19.871

Review 4.  Regulation of cellular energy metabolism.

Authors:  M Erecińska; D F Wilson
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

5.  Triosephosphates modulate leaf mitochondrial phosphorylation by inhibition and uncoupling of electron transport.

Authors:  R Hampp
Journal:  Plant Physiol       Date:  1985-11       Impact factor: 8.340

Review 6.  Energetic depression caused by mitochondrial dysfunction.

Authors:  Frank Norbert Gellerich; Sonata Trumbeckaite; Tobias Müller; Marcus Deschauer; Ying Chen; Zemfira Gizatullina; Stephan Zierz
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

7.  Synthesis of phosphatidylcholine and phosphatidylglycerol in rat lung mitochondria.

Authors:  M Schlame; B Rüstow; D Kunze
Journal:  Mol Cell Biochem       Date:  1989-02-21       Impact factor: 3.396

8.  ATP binding to cytochrome c diminishes electron flow in the mitochondrial respiratory pathway.

Authors:  D B Craig; C J Wallace
Journal:  Protein Sci       Date:  1993-06       Impact factor: 6.725

9.  Oxaloacetic acid mediates ADP-dependent inhibition of mitochondrial complex II-driven respiration.

Authors:  Brian D Fink; Fan Bai; Liping Yu; Ryan D Sheldon; Arpit Sharma; Eric B Taylor; William I Sivitz
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

10.  Voltage-Dependent Regulation of Complex II Energized Mitochondrial Oxygen Flux.

Authors:  Fan Bai; Brian D Fink; Liping Yu; William I Sivitz
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.